| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 1e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-05 |